Why the study?
Does a clinical pharmacist providing bedside care reduce 30-day cardiac-related readmission in patients with acute coronary syndromes?
Population
Patients admitted to and discharged from the general cardiology unit for acute coronary syndromes (ACS)
Comparison
Clinical pharmacist providing care at the… vs Standard practice care
Design
Cohort, nonrandomized
Follow-up
30 days
Authors
Loading...
No overall reduction in 30-day cardiac readmissions with pharmacist care in ACS; hypothesis-generating for unstable angina and requires prospective validation.
Does a clinical pharmacist providing bedside care reduce 30-day cardiac-related readmission in patients with acute coronary syndromes?
The addition of a clinical pharmacist to the care team did not reduce overall 30-day cardiac readmissions in ACS patients, though hypothesis-generating benefits were seen in unstable angina.
O'Del et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: